Date: November 1, 2023
Time: 05:30PM - 06:30PM
Chimeric antigen receptor (CAR)-T cell therapy is a promising new immunotherapy for certain cancers of the blood, providing long-lasting responses for some patients. It genetically modifies T cells to make them specific for cancer cell markers and activates the immune system to destroy cancer cells. Physicians with the CAR-T cell therapy program at Mayo Clinic in Jacksonville, Florida, will discuss current uses and potential future applications. Mayo Clinic’s program includes an in-house cell manufacturing facility for developing new cutting-edge trials.
Target Audience:
Webinar is open to physicians, physician assistants, nurses, nurse practitioners, residents, fellows, pharmacists, social workers, scientists, students, and allied health professionals. Also for medical directors or others from contracted organizations.
Learning Objectives: